U.S. SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
---------------------------
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) OCTOBER 23, 2003
----------------
Diagnostic Products Corporation
-------------------------------
(Exact name of Registrant as specified in its charter)
California 1-9957 95-2802182
---------- ------ ----------
(State or other (IRS Employer
jurisdiction of incorporation) (Commission File Number) Identification No.)
5700 West 96th Street, Los Angeles, California 90045
----------------------------------------------------
(Address of principal executive offices) (Zip Code)
(310) 645-8200
-------------
(Registrant's telephone number, including area code)
Diagnostic Products Corporation
Current Report on Form 8-K
ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS.
(c) Exhibits.
No. 99.1 Press Release issued by Diagnostic Products Corporation,
dated October 23, 2003.
ITEM 12. RESULTS OF OPERATIONS AND FINANCIAL CONDITION.
On October 23, 2003, Diagnostic Products Corporation announced its
results of operations for the quarter ended September 30, 2003. A copy of the
related press release is being furnished as Exhibit 99.1 to this Form 8-K and is
incorporated herein by reference in its entirety.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Dated: October 23, 2003 Diagnostic Products Corporation
By: /s/ James L. Brill
------------------
James L. Brill,
Vice President, Finance
2
EXHIBIT INDEX
Exhibit Number
- --------------
99.1 Press Release issued by Diagnostic Products Corporation,
dated October 23, 2003.
3